CALR c.217C>G ;(p.R73G)

Variant ID: 19-13050265-C-G

NM_004343.3(CALR):c.217C>G;(p.R73G)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC.

Frontiers In Oncology
He, Ping P; Liu, Jie J; Xu, Qingyuan Q; Ma, Huaijun H; Niu, Beifang B; Huang, Gang G; Wu, Wei W
Publication Date: 2023

Variant appearance in text: CALR: 217C>G; R73G
PubMed Link: 36910641
Variant Present in the following documents:
  • DataSheet_1.xlsx, sheet 8
View BVdb publication page



Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature.

Frontiers In Oncology
Ayres-Silva, Jackline P JP; Bonamino, Martin H MH; Gouveia, Maria E ME; Monte-Mor, Barbara C R BCR; Coutinho, Diego F DF; Daumas, Adelmo H AH; Solza, Cristiana C; Braggio, Esteban E; Zalcberg, Ilana Renault IR
Publication Date: 2018

Variant appearance in text: CALR: Arg73Gly
PubMed Link: 29515972
Variant Present in the following documents:
  • table_1.xlsx, sheet 1
View BVdb publication page